期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

甲状腺未分化癌的诊疗进展 被引量：4

原文传递
导出
摘要 甲状腺未分化癌（anaplastic thyroid carcinoma，ATC）是人类最具侵袭性的实体肿瘤之一，确诊后的中位生存期仅3～5个月。据统计ATC占甲状腺癌的1％～3％，但超过14％-50％的甲状腺癌患者死亡是ATC造成的。ATC目前尚无有效治疗，且存在诸多争议。本文就目前的治疗理念、新近临床试验结果及今后研究化疗药物的分子生物学方向做一综述。
作者 屠燕 沈美萍
机构地区 南京医科大学第一附属医院普外科
出处 《中华内分泌外科杂志》 CAS 2013年第4期287-290,共4页 Chinese Journal of Endocrine Surgery
基金 基金项目：江苏省科技厅国际合作计划（BZ2009053）
关键词 甲状腺未分化癌 CARCINOMA 诊疗 有效治疗 中位生存期 分子生物学 实体肿瘤 甲状腺癌
分类号 R736.1 [医药卫生—肿瘤]
  • 相关文献

参考文献29

  • 1Kebebew E, Greenspan FS, Clark OH, et al. Anaplastic thyroid car- cinoma. Treatment outcome and prognostic factors [ J ]. Cancer,2005, 103 (7) : 1330-1335.
  • 2Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma trea- ted in the united states during 1996.
  • 3U.S. and German thyroid cancer study group. An american college of surgeons Commission on cancer patient care evaluation study [ J 1. Cancer,2000,89 ( 1 ) : 202-217.
  • 4Kitagawa W, Shimizu K, Akasu H, et al. Endocrine surgery. The ninth report: the latest data on and clinical characteristics of the epidemiology of thyroid carcinoma [ J ]. J Nippon Med Sch,2003, 70(1) :57-61.
  • 5Ratnatunga PC, Amarasinghe SC, Ratnatunga NV. Changing pat- terns of thyroid cancer in Sri Lanka. Has the iodination programme helped[ J] ? Ceylon Med J,2003,48 (4) : 125-128.
  • 6Reynolds RM, Weir J, Stockton DL, et al. Changing trends in in- cidence and mortality of thyroid cancer in Scotland[J]. Clin Endo- crinol (Oxf) ,2005,62 (2) : 156-162.
  • 7Besic N, Hocevar M, Zgajnar J. Lower incidence of anaplastic car- cinoma after higher iodination of salt in Slovenia [ J ]. Thyroid, 2010,20 (6) :623-626.
  • 8Chiacchio S, Lorenzoni A, Boni G, et al. Anaplastic thyroid canc- er: prevalence, diagnosis and treatment[ J]. Minerva Endocrinol, 2008,33 (4) :341-357.
  • 9Neff RL, Farrar WB, Kloos RT, et al. Anaplastic thyroid cancer [J]. Endocrinol Metab Clin North Am,2008,37(2) :525-538.
  • 10Committee AJC. AJCC cancer staging manual. 7th[ M]. Chicago: AJCC ,2010. Ito Y, Higashiyama T, Hirokawa M, et al. Investigation of the va- lidity of UICC stage grouping of anaplastic carcinoma of the thyroid [ J]. Asian J Snrg,2009,32( 1 ) :47-50.

二级参考文献13

  • 1武忠弼 杨光华主编.中华外科病理学[M].北京：人民卫生出版社,2002.646.
  • 2Takano T, ho Y, Hirokawa M, et al. BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas[J]. Br J Cancer, 2007,96(10):1549
  • 3Kihara M, Miyauchi A, Yamauchi A, et al. Prognostic factors of anaplastic thyroid carcinoma[J]. Surg Today, 2004,34(5):39
  • 4Ain KB, Egorin MJ, DeSimone PA, et al. Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six- hour infusion[J]. Thyroid, 2000,10(7 ):587
  • 5Besic N, Hocevar M, Zgajnar J, et al. Prognostic factors in anaplastic carcinoma of the thyroid-a multivariate survival analysis of 188 patients[J]. Langenbecks Arch Surg, 2005,390(3):203
  • 6Sugitani I, Kasai N, Fujimoto Y, et al. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid [J]. World J Surg, 2001,25(5):617
  • 7Iwasa K, Noquchi M, Mori K, et al. Anaplastic thyroid carcinoma producing the granulocyte colony stimulating factor (G-CSF):report of a case[J]. Surg Today, 1995,25(2): 158
  • 8Yazawas S,Toshimori H, Nakatsura K, et al. Thyroid anaplastic carcinoma producing granulocyte-colony-stimulating factor and parathyroid hormone-related protein[J]. Intern Med, 1995,34(6):584
  • 9Fujita T, Ogasawara Y, Naito M, et al. Anaplastic thyroid carcinoma associated with granulocyte colony-stimulating factor: report of a case [J]. Surg Today, 2006, 36(1):63
  • 10Asakawa H, Kobayashi T. The secretion of cytokines and granulocyte colony stimulating factor by anaplastic and poorly differentiated thyroid carcinoma cell lines[J]. Anticancer Res, 1999,19(1B):761

共引文献13

同被引文献27

  • 1陈国芳,刘超.2012年美国甲状腺学会甲状腺未分化癌诊治指南解读[J].中华内分泌代谢杂志,2014,30(4). 被引量：10
  • 2Vaupel P, Mayer A. Hypoxia in cancer: significance and im- paet on clinical outcome [J]. Cancer Metastasis Rev, 2007. 26 ( 2 ) : 225-239.
  • 3Koh MY, Spivakt-Kroizman TR. Powis G. HIF-la and cancer therapy [J]. Cancer Res, 2010, 180 (7): 15-34.
  • 4Uehara M, Sano K, lkeda H, et al. Hypoxia-inducible factor 1 alpha in oral squamous cell carcinoma and its relation to proslosis [J]. Oral Oncol, 2009, 45 (3): 241-246.
  • 5Cheng ZX, Sun B, Wang SJ, et al. Nuclear factor-KB-dependent epithelial to mesenchymal transition induced by HIF-1α activa- tion in pancreatic cancer cells under hypoxic conditions [J]. PLoS One, 2011, 6(8): e23752.
  • 6Doublier S, Belisario DC, Polimeni M, et ol. HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P- glycoprotein expression: a potential model of the chemo-resis- tance of invasive micropapillary carcinoma of the breast [J]. BMC Cancer, 2012, 12(1): 4-19.
  • 7Zhou YF, Zheng XW, Zhang GH, et al. The effect of hypoxia- inducible factor 1-alpha on hypoxia -induced apoptosis in pri- mary neonatal rat ventricular myocytes [J]. Cardiovasc J Afr, 2010, 21 (1): 37-41.
  • 8Yeo EJ, Chun YS, Cho YS, et ol. YC-I: a potential anticaneer drug targeting hypoxia -inducible factor 1 [J]. J Natl Cancer Inst, 2003, 95 (7): 516-525.
  • 9Nishioka R, Itoh S, Gui T, et al. SNAIL induces epithelial-to- mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo [J]. Exp Mol Pathol, 2010, 89 (2): 149-157.
  • 10Blechschmidt K, Sassen S, Schmalfeldt B, et al. The E-cad-herin repressor Snail is associated with lower overall survival of ovarian cancer patients [J]. Br J Cancer, 2008, 98 (2): 489- 495.

引证文献4

二级引证文献13

中华内分泌外科杂志
2013年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部